STAT+: Merck strikes voluntary licensing deals in poor countries for an experimental HIV prevention pill
Amid rising concern over efforts to contain HIV, Merck has reached voluntary licensing deals with seven companies to...
Tema
STAT
A new, separate outbreak of the diarrhea-causing parasite
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here....
STAT+: White House offers its science blueprint: More AI, less life sciences
For 18 months, the Trump administration has been accused by science advocates of shredding a social contract between...
STAT+: New data on Eli Lilly’s ‘triple-G’ drug leave open questions on heart benefit
Eli Lilly reported more results Thursday showing that its next-generation obesity drug is highly efficacious at...
STAT+: FDA staff and peptide enthusiasts set to clash at advisory panel
As more Americans experiment with synthetic peptides despite warnings about their unproven benefits and potential...
Opinion: STAT+: Hospitals’ AI may be drifting. Who’s watching?
Walk into almost any U.S. hospital today and you will find AI doing some of the important work of medicine: drafting...
Opinion: STAT+: I’m a cardiologist. I’m not sure the new cholesterol drug enlicitide is a game-changer
A long-awaited moment in preventive cardiology arrived last week, when enlicitide (which Merck is selling under the...
STAT+: Federal health quality research grants worth $109 million ended early
Dozens of researchers funded by the federal Agency for Healthcare Research and Quality received notices last week...
STAT+: ‘Cochlear implant for blindness’ debuts in Europe, could launch in U.S. in 2027
Europeans can now receive a device that can partially restore their vision loss. Americans may not have to wait long...
STAT+: More workers hate their jobs, but keep them for the health insurance
An increasing number of adults are slogging through jobs they don’t like solely because they don’t...
STAT+: Novo Nordisk sues Eli Lilly over GLP-1 drug ads it calls ‘deceptive’
Novo Nordisk on Tuesday sued Eli Lilly for allegedly running a “deceptive” ad campaign that uses...
STAT+: Bristol Myers Squibb becomes latest company to claim it’s building pharma’s largest NVIDIA AI supercomputer
It’s officially a trend. For the third time in nine months, a pharma company has announced that it is...
Página 1
Mais →